Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.
Employees - 27,
CEO - Mr. Steven M. Foster,
Sector - Healthcare,
Country - US,
Market Cap - 8.24M
Altman ZScore(max is 10): -11.84, Piotroski Score(max is 10): 2, Working Capital: $6341000, Total Assets: $9843000, Retained Earnings: $-68746000, EBIT: -13669000, Total Liabilities: $3872000, Revenue: $3315000
- Current Price $1.33 - Analyst Target Price $3.00| Ticker | TNON |
| Index | - |
| Curent Price | 1.33 |
| Change | -9.52% |
| Market Cap | 8.24M |
| Average Volume | 7.15M |
| Income | -13.67M |
| Sales | 3.28M |
| Book Value/Share | 0.71 |
| Cash/Share | 1.06 |
| Dividend Est | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Employees | 27 |
| Moving Avg 20days | -16.26% |
| Moving Avg 50days | -12.73% |
| Moving Avg 200days | -58.40% |
| Shares Outstanding | 6.20M |
| Earnings Date | Mar 20 AMC |
| Inst. Ownership | 1.40% |
| Price/Earnings | - |
| Forwad P/E | - |
| PE Growth | - |
| Price/Sales | 2.51 |
| Price/Book | 1.88 |
| Price/Cash | 1.26 |
| Price/FCF | - |
| Quick Ratio | 4.07 |
| Current Ratio | 4.39 |
| Debt/Equity | 0.07 |
| Return on Assets | -168.93% |
| Return on Equity | -405.19% |
| Return on Investment | -223.71% |
| Gross Margin | 37.75% |
| Ops Margin | -420.08% |
| Profit Margin | -417.24% |
| RSI | 46.20 |
| BETA(β) | 1.17 |
| From 52week Low | 46.23% |
| From 52week High | -91.58% |
| EPS | -22.81 |
| EPS next Year | -1.35 |
| EPS next Qtr | -1.06 |
| EPS this Year | 69.98% |
| EPS next 5 Year | - |
| EPS past 5 Year | -25.43% |
| Sales past 5 Year | 182.89% |
| EPS Y/Y | 87.83% |
| Sales Y/Y | 11.92% |
| EPS Q/Q | 89.80% |
| Sales Q/Q | -4.70% |
| Sales Surprise | -11.21% |
| EPS Surprise | 379.31% |
| ATR(14) | 0.53 |
| Perf Week | -52.50% |
| Perf Month | 2.31% |
| Perf Quarter | -29.26% |
| Perf Year | -82.54% |
| Perf YTD | -29.26% |
| Target Price | 3.00 |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer